The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology. Traditionally, asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose. Recommended Asthma Inhaler GuidelinesAsthma guidelines and patient instructions for inhaled medications recommend that
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Philips, DispatchHealth Launch On-Demand Home Care Pilot Program for Arizona Seniors
Philips is joining forces on a pilot study with DispatchHealth, a provider of mobile urgent care that delivers convenient, affordable care within one’s home to help enhance care for select Arizona members of Mercy Care. DispatchHealth supports seniors wishing to stay in their homes longer by providing a preventative and proactive treatment where and when seniors need it to help avoid elevating health situations to costly emergency medical services (EMS) and to avoid unnecessary trips to
Read More
ICON Acquires Precision Medicine for Oncology Company MolecularMD
ICON, a global provider of drug development solutions and services has acquired MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology. The acquisition of MolecularMD’s extensive scientific and clinical biomarker experience expands the ICON’s capabilities in molecular diagnostic testing and also adds expanded testing platforms, including next-generation sequencing and immunohistochemistry, to ICON’s
Read More
HIMSS19 Agrees – 2019 Will be a Big Year for Telehealth
Telehealth has been a key theme at HIMSS for several years now; that said, it has never quite lived up to its own hype and to some extent has been viewed as a “niche” area compared to some of its bigger brothers such as EHR and population health. The back-end of 2018 and start of 2019 saw developments that are likely to change this in the near future.The Centers for Medicare & Medicaid Services (CMS) updated several of its guidance models and the 2019 physician fee schedule in relation to
Read More
Study: VR-AI Therapy Cuts Night Flashes in Half for Cancer Patients
A new clinical study from VRHealth cites that breast cancer patients reduced hot flashes and night sweats by 50% using VR-AI therapy coaching environment. In addition, study participants reported significant improvements in their sleep quality and fewer disruptions to their daily lives following a three-week experiment with the VR solution. VRHealth is a digital health company focused on helping clinicians better manage their patients' care via specialized virtual reality (VR) technology
Read More
Dosis Expands AI-Powered Strategic Anemia Advisor to 50 Clinics
Dosis, a San Francisco, CA-based developer of the Strategic Anemia Advisor (SAA) decision support tool, announced today that it has expanded its AI-powered personalized dosing platform to support to 50 dialysis clinics and 5,000 patients across the country. More than 550,000 End-Stage Renal Disease (ESRD) patients in the U.S. are currently undergoing dialysis treatment across the country, and the vast majority of those patients experience chronic anemia that requires dosing
Read More
Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More
Ochsner Health and Pfizer to Develop Innovative Models for Clinical Trials
Ochsner Health System and Pfizer Inc, today announced it has entered into a multi-year strategic alliance to develop innovative models for clinical trials that will explore ways to enhance the clinical trial experience and ease participation in clinical research for both patients and healthcare professionals. Through its innovation lab, innovationOchsner (iO), in partnership with Oschner Research, the alliance aims to create faster, improved access and connectivity to clinical trials for
Read More
NarrativeDx Raises $3M for Patient Experience Intelligence Platform
NarrativeDx, an Austin, TX-based artificial intelligence (AI) company that provides actionable insights from patient and provider feedback, today announced it has raised $3 million in strategic funding led by Christiana Care Health System, Summation Health Ventures and The Texas Medical Center. Also joining the round are HealthX Ventures and Cultivation Capital, who participated in previous rounds of funding. NarrativeDx will use the funds to accelerate sales and marketing, product innovation,
Read More
Emedgene Lands $6M to Expand AI-Driven Genomics Interpretation Platform
Emedgene, a Palo Alto, CA-based artificial intelligence (AI) driven genomics interpretation platform, today announced it has raised $6 million in funding led by health-focused OliveTree Ventures. The company plans to utilize the latest round of funding to expand sales operations in the US. Emedgene's Genomics Intelligence Platform OverviewThis rise in genomics-based medicine is putting tremendous pressure on geneticists globally - who must analyze and interpret each test. It is a costly,
Read More
